Resource Hub search

Whilst supporting the change to cervical screening intervals in England, the IBMS calls for a trained workforce to safely support the transition.

Ensuring biomedical science leads NHS reform

Investing in diagnostic capacity, digital transformation, and a robust biomedical science workforce is essential to delivering faster, more equitable elective care for all

IBMS responds to Thérèse Coffey MP's policy paper ‘Our Plan for Patients’

Following the suspension of a COVID-19 testing laboratory in Wolverhampton, the IBMS publicly reiterates the need for a regulated workforce and laboratory accreditation for mass testing centres.

In response to service need, and with the support from all UK health departments, the IBMS and the Royal College of Pathologists (RCPath) have jointly developed and introduced a UK wide recognised training and examination framework to enable the scientist workforce to take on certain functions that have previously been the sole responsibility of medically qualified staff.

The IBMS outlines and assesses the principal rapid testing options currently available for the SARS-CoV-2 virus (COVID-19).

The IBMS outlines and assesses the principal testing options currently available for the SARS-CoV-2 virus (COVID-19).

IBMS Council delivers a position statement on the need for registered staff and accreditation in laboratories doing COVID-19 testing

The IBMS issues a response to The Independent’s news story “Failing the test: Slow start and flawed decisions in Britain’s coronavirus testing have cost lives, warn health leaders”.

As we await the government’s announcement on its 100,000 ‘test’ target, the IBMS members and laboratory staff are working tirelessly to prepare for the next phase of the coronavirus pandemic

COVID-19: IBMS statement on the use of personal protective equipment (PPE) in pathology laboratories